Dixon Mitchell Investment Counsel’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.6M Sell
75,190
-613
-0.8% -$309K 1.24% 29
2025
Q4
$35.4M Buy
75,803
+1,699
+2% +$789K 1.17% 27
2025
Q3
$31.6M Buy
74,104
+2,261
+3% +$876K 1.12% 30
2025
Q2
$27.6M Buy
71,843
+4,625
+7% +$1.67M 1.07% 29
2025
Q1
$23.3M Buy
67,218
+661
+1% +$213K 1.05% 31
2024
Q4
$20M Buy
66,557
+15,146
+29% +$5.29M 0.92% 35
2024
Q3
$20.9M Buy
51,411
+2,978
+6% +$1.09M 0.95% 34
2024
Q2
$15.7M Buy
48,433
+886
+2% +$288K 0.79% 35
2024
Q1
$15.9M Sell
47,547
-699
-1% -$214K 0.79% 37
2023
Q4
$13.1M Sell
48,246
-1,230
-2% -$304K 0.69% 40
2023
Q3
$12.2M Sell
49,476
-785
-2% -$215K 0.74% 39
2023
Q2
$15.3M Sell
50,261
-9,823
-16% -$2.73M 0.87% 38
2023
Q1
$15.8M Sell
60,084
-17,748
-23% -$4.51M 0.99% 31
2022
Q4
$18.7M Buy
77,832
+2,574
+3% +$576K 1.25% 27
2022
Q3
$13.8M Sell
75,258
-1,060
-1% -$211K 1.03% 32
2022
Q2
$12.8M Buy
76,318
+25,977
+52% +$5.58M 0.92% 34
2022
Q1
$12.6M Buy
50,341
+2,057
+4% +$517K 0.75% 40
2021
Q4
$12.4M Buy
48,284
+2,657
+6% +$650K 0.77% 37
2021
Q3
$11.1M Sell
45,627
-5,466
-11% -$1.34M 0.78% 40
2021
Q2
$10.6M Sell
51,093
-542
-1% -$110K 0.78% 38
2021
Q1
$9.72M Sell
51,635
-14,117
-21% -$2.49M 0.81% 38
2020
Q4
$10.8M Sell
65,752
-28,818
-30% -$4.21M 0.93% 32
2020
Q3
$11.8M Buy
94,570
+2,944
+3% +$364K 1.16% 28
2020
Q2
$8.89M Sell
91,626
-489
-0.5% -$50.8K 0.98% 32
2020
Q1
$8.28M Buy
92,115
+16,488
+22% +$2.13M 1.04% 30
2019
Q4
$11.2M Buy
75,627
+7,455
+11% +$1M 1.19% 30
2019
Q3
$8.21M Buy
68,172
+14,717
+28% +$1.9M 0.94% 36
2019
Q2
$7.23M Buy
53,455
+4,897
+10% +$619K 0.82% 35
2019
Q1
$6.33M Buy
48,558
+25,999
+115% +$3.49M 0.75% 39
2018
Q4
$2.81M Sell
22,559
-36,718
-62% -$4.93M 0.38% 52
2018
Q3
$8.25M Sell
59,277
-365
-0.6% -$45.4K 0.96% 31
2018
Q2
$6.12M Buy
59,642
+105
+0.2% +$10.6K 0.77% 37
2018
Q1
$5.78M Sell
59,537
-724
-1% -$70.2K 0.76% 40
2017
Q4
$5.29M Buy
60,261
+1,567
+3% +$126K 0.68% 42
2017
Q3
$4.67M Buy
58,694
+2,311
+4% +$186K 0.62% 44
2017
Q2
$4.92M Buy
56,383
+1,793
+3% +$152K 0.69% 40
2017
Q1
$4.86M Sell
54,590
-24,484
-31% -$2.04M 0.7% 40
2016
Q4
$5.85M Sell
79,074
-9,395
-11% -$704K 0.88% 35
2016
Q3
$6.69M Buy
88,469
+7,962
+10% +$610K 1.04% 30
2016
Q2
$6.2M Sell
80,507
-16,405
-17% -$1.29M 1.03% 30
2016
Q1
$7.56M Sell
96,912
-4,382
-4% -$306K 1.23% 28
2015
Q4
$6.85M Buy
101,294
+4,729
+5% +$330K 1.16% 29
2015
Q3
$7.47M Buy
96,565
+50,171
+108% +$4.44M 1.29% 26
2015
Q2
$4.21M Buy
+46,394
New +$3.72M 0.65% 42

Other funds holding HCA

Dixon Mitchell Investment Counsel's HCA Position: Q1 2026 in Review

Dixon Mitchell Investment Counsel reduced its HCA Healthcare (HCA) stake by 0.81% in Q1 2026, selling an estimated $309K and leaving 75,190 shares worth $35.6M. The position accounts for 1.24% of the portfolio, ranked #29.

Dixon Mitchell Investment Counsel first reported a position in HCA in Q2 2015 and has held it in 44 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Dixon Mitchell Investment Counsel held 75,190 shares of HCA Healthcare worth $35.6M as of Q1 2026.
  • Dixon Mitchell Investment Counsel sold 613 HCA Healthcare shares in Q1 2026, an estimated $309K.
  • HCA Healthcare made up 1.24% of Dixon Mitchell Investment Counsel's portfolio in Q1 2026, its #29 holding.
  • Dixon Mitchell Investment Counsel first reported a position in HCA Healthcare in Q2 2015 and has held it in 44 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.